ID: ALA323719

Max Phase: Preclinical

Molecular Formula: C15H23N3O

Molecular Weight: 261.37

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCOc1nccnc1C1CN2CCC1CC2

Standard InChI:  InChI=1S/C15H23N3O/c1-2-3-10-19-15-14(16-6-7-17-15)13-11-18-8-4-12(13)5-9-18/h6-7,12-13H,2-5,8-11H2,1H3

Standard InChI Key:  PLPNZJVLQVYLAH-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 261.37

Molecular Weight (Monoisotopic): 261.1841

AlogP: 2.46

#Rotatable Bonds: 5

Polar Surface Area: 38.25

Molecular Species: NEUTRAL

HBA: 4

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 7.85

CX LogP: 1.89

CX LogD: 1.30

Aromatic Rings: 1

Heavy Atoms: 19

QED Weighted: 0.76

Np Likeness Score: -0.23

References

1. Ward JS, Merritt L, Calligaro DO, Bymaster FP, Shannon HE, Sawyer BD, Mitch CH, Deeter JB, Peters SC, Sheardown MJ, Olesen PH, Swedberg MD, Sauerberg P..  (1995)  Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.,  38  (18): [PMID:7658434] [10.1021/jm00018a007]

Source

Source(1):

• Scientific Literature